However, this protocol is off-label and should only be done with provider guidance
6.1 Lipid nanoparticles Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs), as the first and second generations of lipid nanoparticles, respectively, have promising characteristics for topical drug delivery purposes
Some of the most common side effects include vomiting, diarrhea and constipation
Rejeesh Menon, MD Medical Director, SuperHuman Program Last reviewed 5 April 2026 Frequently Asked Questions FAQ: Mounjaro in India Mounjaro is the brand name for tirzepatide, a once-weekly injectable medication that activates both GIP and GLP-1 receptors
The provider must evaluate your medical history, BMI, and current health status to ensure the medication is appropriate for you
Since then, Ive carried emergency sugars